Tyra Biosciences Inc Earnings

The next earnings date for Tyra Biosciences Inc has not yet been scheduled.

Analyst Estimates of Tyra Biosciences Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tyra Biosciences Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
10/30/2025---$0100.00%
08/14/2025---$-0.4711.32%
08/07/2025---$0100.00%
05/29/2025After Market$-0.471.30%
11/08/2024---$-0.41-4.59%
08/08/2024Before Market$-0.3221.95%
05/09/2024After Market$-0.3523.91%
03/19/2024After Market$-0.53-10.42%
11/07/2023After Market$-0.49-40.00%
08/10/2023After Market$-0.318.82%
05/04/2023After Market$-0.2824.32%
03/22/2023After Market$-0.3113.89%
11/03/2022After Market$-0.3026.83%
08/04/2022After Market$-0.36-12.50%
05/05/2022After Market$-0.36-80.00%
03/03/2022After Market$-0.24-14.29%
11/03/2021After Market$-0.72-148.28%
09/15/2021After Market$-0.24---
05/28/2021---$-0.04---
03/31/2021---$-2.09---
12/31/2020---$-1.80---
09/30/2020---$-1.80---
06/30/2020---$-1.27---
03/31/2020---$-1.07---

More About Tyra Biosciences Inc

Country
USA
Full Time Employees
60

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Tyra Biosciences Inc Earnings” Can Refer to the Tyra Biosciences Inc Earnings Date

Some people say “Tyra Biosciences Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tyra Biosciences Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tyra Biosciences Inc Stock on the Earnings Date

If you own Tyra Biosciences Inc stock (TYRA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tyra Biosciences Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tyra Biosciences Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tyra Biosciences Inc Earnings

You can contact us any time if you would like to ask questions about Tyra Biosciences Inc earnings or anything else related to the stock market.